Jin Xing Qi
Chairman chez HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Fortune : 1 642 M $ au 31/03/2024
Profil
Jin Xing Qi a fondé Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Il est actuellement président de Hangzhou Binjiang Real Estate Group Co., Ltd. et président de Hangzhou Pute Equity Investment Co. Ltd. M. Qi est également membre du conseil d'administration de Hangzhou Binjiang Investment Holding Co. Ltd. et de Hangzhou Xincheng Time Square Real Estate Co. Ltd. et vice-président de Zhejiang Management Research. Par le passé, M. Qi a occupé le poste de directeur chez Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Jin Xing Qi a obtenu un MBA de l'université de Zhejiang.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 1 505 912 522 ( 55,93% ) | 1 386 M $ | 31/03/2024 | |
| 30/09/2023 | 278 698 950 ( 64,95% ) | 256 M $ | 31/03/2024 |
Postes actifs de Jin Xing Qi
| Sociétés | Poste | Début |
|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Chairman | 01/01/2003 |
| Zhejiang Management Research | Corporate Officer/Principal | 24/02/2010 |
| Hangzhou Pute Equity Investment Co. Ltd. | Chairman | 07/04/2011 |
Hangzhou Binjiang Investment Holding Co., Ltd.
 Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding private company based in Hangzhou, China. | Director/Board Member | - |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
 Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The private company is based in Hangzhou, China. | Director/Board Member | - |
Anciens postes connus de Jin Xing Qi
| Sociétés | Poste | Fin |
|---|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Founder | - |
Formation de Jin Xing Qi
| Zhejiang University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| Entreprise privées | 5 |
|---|---|
Hangzhou Binjiang Investment Holding Co., Ltd.
Hangzhou Binjiang Investment Holding Co., Ltd. MiscellaneousMiscellaneous Hangzhou Binjiang Investment Holding Co., Ltd. is an investment holding private company based in Hangzhou, China. | Miscellaneous |
| Zhejiang Management Research | |
Hangzhou Xincheng Time Square Real Estate Co., Ltd.
Hangzhou Xincheng Time Square Real Estate Co., Ltd. Real Estate DevelopmentFinance Part of Hangzhou Binjiang Real Estate Group Co., Ltd., Hangzhou Xincheng Time Square Real Estate Co., Ltd. develops and manages real estate property. The private company is based in Hangzhou, China. | Finance |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Hangzhou Pute Equity Investment Co. Ltd. | Finance |
